Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-11-08

FDA Approved: HYDROXYZINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved Teva's supplemental application for hydroxyzine hydrochloride, confirming approval of an additional submission for this generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HYDROXYZINE HYDROCHLORIDE (Hydroxyzine hydrochloride)

Snippet

SUPPL AP for HYDROXYZINE HYDROCHLORIDE (HYDROXYZINE HYDROCHLORIDE)